Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5014344 | 1.00 | ALDH1A1 (0.30) | ALDH1A1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL5033531 | 0.94 | ALDH1A1 (0.32) | ALDH1A1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL5033533 | 0.94 | ALDH1A1 (0.32) | ALDH1A1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL5048623 | 0.81 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL5033432 | 0.80 | — | — | |
| SCHEMBL5012313 | 0.74 | ALDH1A1 (0.32) | ALDH1A1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5015659 | 0.72 | ALDH1A1 (0.31) | ALDH1A1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5015660 | 0.72 | ALDH1A1 (0.31) | ALDH1A1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5026024 | 0.71 | — | — | |
| SCHEMBL5033843 | 0.71 | ALDH1A1 (0.32) | ALDH1A1SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080053835-A1 | Monomer Compound, Process for Producing the Same, Polymer Thereof, and Water-Based Curable Composition | KANSAI PAINT CO., LTD. (JP) | 2008-03-06 | — | — | US | disclosed |
| EP-1798218-A1 | MONOMER COMPOUND, PROCESS FOR PRODUCING THE SAME, POLYMER THEREOF, AND WATER-BASED CURABLE COMPOSITION | KANSAI PAINT CO., LTD. (JP) | 2007-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080053835-A1 | Monomer Compound, Process for Producing the Same, Polymer Thereof, and Water-Based Curable Composition | THEM6, PAM, WEE1 | ALDH1A1 741/4885SLC6A2 4712/4885SLC6A4 3397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.